Barrier abnormality due to ceramide deficiency leads to psoriasiform inflammation in a mouse model

Journal of Investigative Dermatology

Volumn 133, Issue 11, 2013, Pages 2555-2565

  Nakajima, Kimiko ^a   Terao, Mika ^b   Takaishi, Mikiro ^a   Kataoka, Sayo ^c   Goto Inoue, Naoko ^d,e   Setou, Mitsutoshi ^e   Horie, Kyoji ^b   Sakamoto, Fumiko ^f   Ito, Masaaki ^f   Azukizawa, Hiroaki ^b   Kitaba, Shun ^b   Murota, Hiroyuki ^b   Itami, Satoshi ^b   Katayama, Ichiro ^b   Takeda, Junji ^b   Sano, Shigetoshi ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c KOCHI UNIVERSITY   (Japan)

^d TOKYO METROPOLITAN UNIVERSITY   (Japan)

^e HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CERAMIDE; GLYCOPROTEIN P 15095; INTERLEUKIN 17; INTERLEUKIN 22; INTERLEUKIN 23; SERINE PALMITOYLTRANSFERASE;

ACANTHOSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BETA DEFENSIN GENE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EPIDERMIS; GENE; HYPERKERATOSIS; IL 22 GENE; IL17A GENE; IL17F GENE; IN VIVO STUDY; INFLAMMATION; INFLAMMATORY INFILTRATE; KERATINOCYTE; LANGERHANS CELL; LYMPH NODE; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PSORIASIS; S100A8 GENE; S100A9 GENE; TH17 CELL; UPREGULATION;

EID: 84885956811     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2013.199     Document Type: Article

References (46)

1. Alessandrini F, Pfister S, Kremmer E et al. (2004) Alterations of glucosylceramide-beta-glucosidase levels in the skin of patients with psoriasis vulgaris. J Invest Dermatol 123:1030-6 (Pubitemid 39586822)
2. Bergboer JG, Zeeuwen PL, Schalkwijk J (2012) Genetics of psoriasis: evidence for epistatic interaction between skin barrier abnormalities and immune deviation. J Invest Dermatol 132:2320-1
3. Cai Y, Shen X, Ding C et al. (2011) Pivotal role of dermal IL-17-producing gammadelta T cells in skin inflammation. Immunity 35:596-610
4. de Cid R, Riveira-Munoz E, Zeeuwen PL et al. (2009) Deletion of the late cornified envelope LCE3B and LCE3C genes as a susceptibility factor for psoriasis. Nat Genet 41:211-5
5. Dickson RC, Lester RL, Nagiec MM (2000) Serine palmitoyltransferase. Methods Enzymol 311:3-9 (Pubitemid 29512744)
6. Elias PM, Menon GK (1991) Structural and lipid biochemical correlates of the epidermal permeability barrier. Adv Lipid Res 24:1-26
7. Feingold KR (2007) Thematic review series: skin lipids. The role of epidermal lipids in cutaneous permeability barrier homeostasis. J Lipid Res 48:2531-46 (Pubitemid 350272838)
8. Fitch E, Harper E, Skorcheva I et al. (2007) Pathophysiology of psoriasis: recent advances on IL-23 and Th17 cytokines. Curr Rheumatol Rep 9:461-7 (Pubitemid 350305203)
9. Ghadially R, Reed JT, Elias PM (1996) Stratum corneum structure and function correlates with phenotype in psoriasis. J Invest Dermatol 107:558-64 (Pubitemid 26338579)
10. Goto-Inoue N, Hayasaka T, Zaima N et al. (2012) Imaging mass spectrometry visualizes ceramides and pathogenesis of dorfman-chanarin syndrome due to ceramide metabolic abnormality in the skin. PLOS ONE 7:e49519
11. Gray EE, Suzuki K, Cyster JG (2011) Cutting edge: identification of a motile IL-17-producing gammadelta T cell population in the dermis. J Immunol 186:6091-5
12. Hwang J, Kita R, Kwon H-S et al. (2012) Epidermal ablation of Dlx3 is linked to IL-17-associated skin inflammation. Proc Natl Acad Sci USA 108:11566-71
13. Holleran WM, Feingold KR, Man MQ et al. (1991) Regulation of epidermal sphingolipid synthesis by permeability barrier function. J Lipid Res 32:1151-8
14. Holleran WM, Gao WN, Feingold KR et al. (1995) Localization of epidermal sphingolipid synthesis and serine palmitoyl transferase activity: alterations imposed by permeability barrier requirements. Arch Dermatol Res 287:254-8
15. HolleranWM, Williams ML, GaoWN et al. (1990) Serine-palmitoyl transferase activity in cultured human keratinocytes. J Lipid Res 31:1655-61 (Pubitemid 20321726)
16. Hollox EJ, Huffmeier U, Zeeuwen PL et al. (2008) Psoriasis is associated with increased beta-defensin genomic copy number. Nat Genet 40:23-5
17. Holzmann S, Tripp CH, Schmuth M et al. (2004) A model system using tape stripping for characterization of Langerhans cell-precursors in vivo. J Invest Dermatol 122:1165-74 (Pubitemid 38651091)
18. Hong KK, Cho HR, Ju WC et al. (2007) A study on altered expression of serine palmitoyltransferase and ceramidase in psoriatic skin lesion. J Korean Med Sci 22:862-7
19. Imokawa G, Abe A, Jin K et al. (1991) Decreased level of ceramides in stratum corneum of atopic dermatitis: an etiologic factor in atopic dry skin? J Invest Dermatol 96:523-6
20. Irvine AD, McLean WH, Leung DY (2011) Filaggrin mutations associated with skin and allergic diseases. N Engl J Med 365:1315-27
21. Jansen M, Groth L, Holmer G et al. (2002) The potential of the essential fatty acid-deficient hairless rat as a psoriasis screening model for topical anti-proliferative drugs. Skin Pharmacol Appl Skin Physiol 15:401-13 (Pubitemid 36005583)
22. Kubo A, Nagao K, Yokouchi M et al. (2009) External antigen uptake by Langerhans cells with reorganization of epidermal tight junction barriers. J Exp Med 206:2937-46
23. Laggner U, Di Meglio P, Perera GK et al. (2011) Identification of a novel proinflammatory human skin-homing Vgamma9Vdelta2 T cell subset with a potential role in psoriasis. J Immunol 187:2783-93
24. Mabuchi T, Takekoshi T, Hwang ST (2011) Epidermal CCR6\+ gammadelta T cells are major producers of IL-22 and IL-17 in a murine model of psoriasiform dermatitis. J Immunol 187:5026-31
25. Melnik B, Hollmann J, Plewig G (1988) Decreased stratum corneum ceramides in atopic individuals-a pathobiochemical factor in xerosis? Br J Dermatol 119:547-9
26. Motta S, Monti M, Sesana S et al. (1993) Ceramide composition of the psoriatic scale. Biochim Biophys Acta 1182:147-51 (Pubitemid 23267037)
27. Motta S, Monti M, Sesana S et al. (1994) Abnormality of water barrier function in psoriasis. Role of ceramide fractions. Arch Dermatol 130:452-6 (Pubitemid 24123365)
28. Nakajima K (2012) Critical role of the interleukin-23/T-helper 17 cell axis in the pathogenesis of psoriasis. J Dermatol 39:219-24
29. Nakajima K, Kanda T, Takaishi M et al. (2011) Distinct roles of IL-23 and IL-17 in the development of psoriasis-like lesions in a mouse model. J Immunol 186:4481-9
30. Nograles KE, Krueger JG (2011) Anti-cytokine therapies for psoriasis. Exp Cell Res 317:1293-300
31. Ohta E, Ohira T, Matsue K et al. (2009) Analysis of development of lesions in mice with serine palmitoyltransferase (SPT) deficiency-Sptlc2 conditional knockout mice. Exp Anim 58:515-24
32. Orru S, Giuressi E, Carcassi C et al. (2005) Mapping of the major psoriasissusceptibility locus (PSORS1) in a 70-Kb interval around the corneodesmosin gene (CDSN). Am J Hum Genet 76:164-71 (Pubitemid 40023776)
33. Palmer CN, Irvine AD, Terron-Kwiatkowski A et al. (2006) Common loss-offunction variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 38:441-6
34. Roberson ED, Bowcock AM (2010) Psoriasis genetics: breaking the barrier. Trends Genet 26:415-23
35. Ruedl C, Koebel P, Bachmann M et al. (2000) Anatomical origin of dendritic cells determines their life span in peripheral lymph nodes. J Immunol 165:4910-6
36. Sa SM, Valdez PA, Wu J et al. (2007) The effects of IL-20 subfamily cytokines on reconstituted human epidermis suggest potential roles in cutaneous innate defense and pathogenic adaptive immunity in psoriasis. J Immunol 178:2229-40 (Pubitemid 46233421)
37. Sano S, Chan KS, Carbajal S et al. (2005) Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model. Nat Med 11:43-9 (Pubitemid 40215836)
38. Sano S, Chan KS, DiGiovanni J (2008) Impact of Stat3 activation upon skin biology: a dichotomy of its role between homeostasis and diseases. J Dermatol Sci 50:1-14 (Pubitemid 351249893)
39. Strid J, Sobolev O, Zafirova B et al. (2011) The intraepithelial T cell response to NKG2D-ligands links lymphoid stress surveillance to atopy. Science 334:1293-7
40. Sumaria N, Roediger B, Ng LG et al. (2011) Cutaneous immunosurveillance by self-renewing dermal gammadelta T cells. J Exp Med 208:505-18
41. Tarutani M, Itami S, Okabe M et al. (1997) Tissue-specific knockout of the mouse Pig-a gene reveals important roles for GPI-anchored proteins in skin development. Proc Natl Acad Sci USA 94:7400-5 (Pubitemid 27345327)
42. Wood LC, Jackson SM, Elias PM et al. (1992) Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice. J Clin Invest 90:482-7
43. Wood LC, Elias PM, Sequeira-Martin SM et al. (1994) Occlusion lowers cytokine mRNA levels in essential fatty acid-deficient and normal mouse epidermis, but not after acute barrier disruption. J Invest Dermatol 103:834-8
44. Wood LC, Stalder AK, Liou A et al. (1997) Barrier disruption increases gene expression of cytokines and the 55kD TNF receptor in murine skin. Exp Dermatol 6:98-104 (Pubitemid 27243600)
45. Wolf R, Orion E, Ruocco E et al. (2012) Abnormal epidermal barrier in the pathogenesis of psoriasis. Clin Dermatol 30:323-8
46. Zheng Y, Danilenko DM, Valdez P et al. (2007) Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 445:648-51 (Pubitemid 46232884)